Paris, France:
Pfizer and BioNTech, makers of a Covid-19 vaccine, stated on Thursday that their solution is productive against coronavirus variants that have emerged in Britain and South Africa.
In a statement, the two firms stated the “small differences” detected in tests comparing the original virus and the current versions “are unlikely to lead to a significant reduction in the effectiveness of the vaccine”.
(This story has not been edited by TheSpuzz employees and is auto-generated from a syndicated feed.)